2015
DOI: 10.1016/j.reprotox.2014.12.003
|View full text |Cite
|
Sign up to set email alerts
|

4-Vinylcyclohexene diepoxide reduces fertility in female Siberian hamsters when treated during their reproductively active and quiescent states

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 36 publications
0
5
0
Order By: Relevance
“…VCD was previously found to accelerate the natural apoptosis of follicles (31), where primary follicles are the main targets of VCD in the ovary. Abnormal VCD secretion is associated with a reduction in the number of viable follicles in the ovaries of patients with DOR (32). In the present study, the results of modeling were evaluated using vaginal smears, which suggested that VCD treatment was ideal for the study of DOR in animal models.…”
Section: Discussionmentioning
confidence: 75%
“…VCD was previously found to accelerate the natural apoptosis of follicles (31), where primary follicles are the main targets of VCD in the ovary. Abnormal VCD secretion is associated with a reduction in the number of viable follicles in the ovaries of patients with DOR (32). In the present study, the results of modeling were evaluated using vaginal smears, which suggested that VCD treatment was ideal for the study of DOR in animal models.…”
Section: Discussionmentioning
confidence: 75%
“…It is possible that the same relationship exists in Syrian hamsters because reduced mate preference was observed at an age at which fertility is reduced [5,10]. We did not evaluate the fertility of VCD-treated Syrian hamsters in this study, but in a previous study involving Siberian hamsters (Phodopus sungorus), fertility and fecundity declined following a comparable VCD regime [25].…”
Section: Discussionmentioning
confidence: 89%
“…The animals in the control group (Group I), each received a single bilateral intra-testicular injection of 0.25 ml of sterile physiological saline, containing 1% lidocaine hydrochloride (a local anaesthetic agent, Astra IDL, Bangalore, India). Groups II and III received a single bilateral intra-testicular injection of 0.25 ml of 15 mg/100 g of calcium chloride dihydrate in saline solution (CaCl 2 , 2H 2 O, Merck, Mumbai, India) and 240 mg/kg of VCM (Aldrich, %98), containing 1% lidocaine hydrochloride, respectively (Jana et al 2002, Roosa et al 2015. Group IV and V received a daily bilateral intra-testicular injection of 15 mg/100 g calcium chloride dihydrate in saline solution and 240 mg/kg of VCM in 1% lidocaine hydrochloride for 3 days, respectively.…”
Section: Experimental Protocolmentioning
confidence: 99%